Similar articles

• The use of theophylline clearance in pediatric status asthmaticus. II. The choice of appropriate dose for the intravenous theophylline infusion.

  Levy J, Kolski GB. Levy J, et al. Am J Dis Child. 1987 Mar;141(3):288-91. doi: 10.1001/archpedi.1987.04460030066026. Am J Dis Child. 1987. PMID: 3101485
• [Treatment of asthmatic crisis in children with immediate-action theophylline].

  Dutau G, Perrin B, Pienkowski C, Gillet A, Sablayrolles B, Rochiccioli P. Dutau G, et al. Ann Pediatr (Paris). 1985 Oct;32(8):735-8. Ann Pediatr (Paris). 1985. PMID: 4073759 French. No abstract available.
• [Clinical evaluation of intravenous theophylline therapy in status asthmaticus].

  Noguchi M, Yoshimura K, Nakatani T, Nakamori Y, Chonabayashi N, Nakata K, Tanimoto H, Murakawa K. Noguchi M, et al. Arerugi. 1988 Nov;37(11):1084-93. Arerugi. 1988. PMID: 3240100 Japanese. No abstract available.
• Clinical and pharmacokinetic concerns of 24-hour dosing with theophylline.

  Weinberger M. Weinberger M. Ann Allergy. 1986 Jan;56(1):2-12. Ann Allergy. 1986. PMID: 3511775 Review.
• Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule.

  Weinberger M, Hendeles L. Weinberger M, et al. Pediatr Pharmacol (New York). 1983;3(3-4):273-85. Pediatr Pharmacol (New York). 1983. PMID: 6429620 Review.